Anzeige
❌
Mehr »
Sonntag, 22.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
12.10.FDA approves Teva's monthly injection of olanzapine for schizophrenia
12.10.FDA approves Asahi Kasei's Hovilpri for refractory HSV
12.10.Perceptive, Nucleus partner to support radiopharmaceutical development
09.10.Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO
09.10.Roche's Tecentriq snags FDA label expansion in type of colon cancer
09.10.Bio-Techne opens GMP small molecule facility in Bristol, UK
09.10.Biohaven partners with Ono in $100m IgG degrader deal
08.10.Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout
08.10.Change lifestyle before giving children weight loss medication, WHO says
08.10.FDA approves Pfizer's Tukysa regimen for metastatic breast cancer
08.10.10x Genomics and Fred Hutch partner on cancer technologies
07.10.CAR-T specialist Caribou culls pipeline and seeks exit deal
07.10.KymaThera pulls in $80m to bring breast cancer drug to clinic
07.10.Rocket receives $150m credit facility to advance cardiovascular portfolio
07.10.Gilead Sciences signs five-year DevOps agreement with Cognizant
06.10.Shionogi bolsters rare disease portfolio with $2bn IntraBio buyout
06.10.Lilly deepens ties with Gate Bioscience in $870m deal expansion
06.10.Alector shares up after sealing $1.27bn Roche Parkinson's disease license deal
06.10.CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug
06.10.Pacira partners with Molteni for Exparel commercialisation
06.10.AstraZeneca opens new R&D centre in Cambridge, US
05.10.Scientists claim Nobel Prize for approach behind light-activated gene therapy
05.10.FDA approves expanded indication for Lilly's Jaypirca
05.10.Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US
02.10.AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact